9999999997-16-023917.txt : 20160620
9999999997-16-023917.hdr.sgml : 20160620
20160620110433
ACCESSION NUMBER: 9999999997-16-023917
CONFORMED SUBMISSION TYPE: CT ORDER
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20160620
DATE AS OF CHANGE: 20160620
20160620
20160620
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: GLOBEIMMUNE INC
CENTRAL INDEX KEY: 0001245104
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 841353925
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: CT ORDER
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35642
FILM NUMBER: 161721585
BUSINESS ADDRESS:
STREET 1: 1450 INFINITE DRIVE
CITY: LOUISVILLE
STATE: CO
ZIP: 80027
BUSINESS PHONE: 3036252744
MAIL ADDRESS:
STREET 1: 1450 INFINITE DRIVE
CITY: LOUISVILLE
STATE: CO
ZIP: 80027
CT ORDER
1
filename1.pdf
begin 644 filename1.pdf
M)5!$1BTQ+C4-)>+CS],-"C$P(# @;V)J#3P\+TQI;F5A7!E+UA2968O5ULQ(#(@,5T^/G-T#0IE;F1S
M=')E86T-96YD;V)J#7-T87)T>')E9@T*, T*)25%3T8-"B @(" @(" @#0HR
M,B P(&]B:@T\/"]&:6QT97(O1FQA=&5$96-O9&4O22 X-"],(#8X+TQE;F=T
M:" V,B]3(#,X/CYS=')E86T-"FC>8F!@8&9@8.)G (.9@94P C$+ P<##0IE;F1S=')E
M86T-96YD;V)J#3$Q(# @;V)J#3P\+TUE=&%D871A(#(@,"!2+U!A9V5,86)E
M;',@-B P(%(O4&%G97,@." P(%(O5'EP92]#871A;&]G/CX-96YD;V)J#3$R
M(# @;V)J#3P\+T-O;G1E;G1S(#$T(# @4B]#%LP(# @-C$R(#7!E+T]B:E-T;3X^4")J]%O/Y\=2,K&IK8ZF7/\O_/=X1\+@0(3(&)@
M$3#/N!@\P8%3$.@8Q'$,5U?D]J#O$BVU,ON[A&$2A?OQF,SJ2INS-.68:\[,
MUL=$)R^;.DN47I'ES8RDZJ#7X[$)_[:$G[)HE=G,@9%DTGTF_3@6A*FHR]:%GDVJ;:% DH2K^;JC=ZU*QY00 NH\T-#S?,\<#$8<6D-=T,3
MG'>_N,)00,B8 3"RRXOB+@>5V/==I(A.N4$06LW=0T_^:,>*&.>;?-K]VNZ[
M>]!'9@J,>=FA.5F_%[SP)7A4O V\_S+G7V NXN]#[JVT<7I&&V>OH*TWY O7
MOWG[&W']"P]ILXQUQ"!K^.J.&ELIBFUDU/D^!^/^Y*LWY KK#CW>>.QG2!L2
M?-[OL3H?:)9PMS<<_A9@ + ]A7T-"F5N9'-T?%;;CN)&$'WG*TK*2SO"O6Z[#7C?&"ZSK#*, AXI4H@B8S>#(X_-MDUF
M^?M47VP8AF $[FMUU3FGJOGRN&;P6O<>XMZ7./:!0;SK,1\\_. K\F#HC>B(
M0_S6\^ 5OW&J?MY[!)SXGQX;@VI'X5]MP QI%YUF7>AZ+U';;>._]
M25Z6BWCFN)Q&9 IKQPWID,0.960.+B:HP$8+Z> AP1T0/Z8?!LO'VT')L]/3XOU>O&\-.:'=#2X,LY:
MXTS'_/U8"O"]/G[9P$3)0NI%%SY=(Q32Z-IHBX)G47A>36'3<$4:^&B_C
MQ?(1G5O.M5?,IYPC'>UNW^X.?;-[,9WACO%O$*]FX_@).Q8LW#@(+SRSFPWN
MZL3XVPQ:M!"GF44'QI,8GN? HD"![Q-N#2(1_$ZD+$"AA/B]+F1O@+-*HR?->U]!%$KSKV0'#BN/PR]+CIGA,H[*@5ST@5:'[=.
MB+(SLWG3B R2$I+#HP&SG_M\FS^SOLD.&L%;.Q_($'UO%@Q(6>/24G
MK%LF/VE;CZZ5A$,WM'FF\2&I\5RT)L5!BAJQT6'7L#W!E8"U6U1]36JOD;58OKCF!2YF6W@+2
MZNU-R%0U*XD0EDFI.WAP)55-- KT26(8&ZHJW1$6=I"&QK:5I%*CXFLNA<@T
M@0&!:H<(6*LA,8,FF'':]%OBAA^N 66Z$RDSO(7P0M=T0B$,_0W9;IP-X1NG
MKP^:ADTNC9A<>IC5FC?D%K_
M[%K'%[/E(BTP7[(;C&CL;(+X)D%V55%4AJF \C;B"T6_JQ(@3!IM2+UQX#TO
M"AW>5IC"Z?//%\$GIZ0HA-8]@J(.-L#@^8;X)C=."*JY>J:'F[
M7AD*\1\!WA#*/C8RL[1N+5Q>7"9_M1YXIP=\UB*5HDGD2=^!_RNJ6=S[3X !
M -13J&P-"F5N9'-TFMC.60B/SX*
M/'@Z>&UP;65T82!X;6QN#IX;7!T:STB
M061O8F4@6$U0($-O&UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D
M8R]E;&5M96YT&UP.D-R96%T;W)4;V]L/@H@(" @(" @
M(" \>&UP.DUO9&EF>41A=&4^,C Q-BTP-BTR,%0Q,#HU.3HU-2TP-#HP,#PO
M>&UP.DUO9&EF>41A=&4^"B @(" @(" @(#QX;7 Z0W)E871E1&%T93XR,#$V
M+3 V+3(P5#$P.C4Y.C4U+3 T.C P/"]X;7 Z0W)E871E1&%T93X*(" @(" @
M(" @/&1C.F9O"UD969A=6QT(CY-:6-R;W-O
M9G0@5V]R9" M(#,S.#@S+F]R9&5R/"]R9&8Z;&D^"B @(" @(" @(" @(#PO
M&UP34TZ26YS
M=&%N8V5)1#YU=6ED.C4V8V%D-3%B+3=D.3@M-&(X-BTX-3,U+3&UP34TZ26YS=&%N8V5)1#X*(" @(" @/"]R9&8Z1&5S8W)I<'1I
M;VX^"B @(#POJ'5!:DZ@?(RQ"H,P
M%$5_Y6TF@S%J([6(('45A):ZN%B38B#XRDNDO]\,G;M